We induced type 1 diabetes in the INK-ATTAC transgenic mice and found that clearance of p16-positive senescent cells with the treatment of AP20187 alleviated kidney injury and the progression of DKD, which supports a direct role of p16-positive senescent cells in DKD. Here, CDKN2A is linked to type 1 diabetes mellitus.